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Introduction
According to the National Cancer Institute, there are several
hundred drugs that have been developed with anti-cancer abilities.
However, cancer is still the second leading cause of death in the
United States according to the CDC. The effectiveness of most anticancer drugs is not limited by its potency but instead by its nontargeted delivery and unwanted side effects. Many cancer
treatments such as chemotherapy can effectively kill cancer cells,
but lack the selectivity and specificity to avoid wreaking havoc on
the rest of the body. Thus, gold nanoparticles (AuNP) have been
employed in an effort to overcome some of the downfalls of current
chemotherapy options. AuNPs have the unique ability to heat upon
exposure to near infrared irradiation and their nanometer sized
dimensions aid in their selective delivery to solid tumors.
Using AuNPs as a platform, the ability to selectively deliver two
different anti-cancer therapeutics via heat sensitive conjugations
was investigated. Two DNA strands of different melting
temperatures were developed separately as potential temperaturesensitive tethers for drug attachment to AuNPs. Fluorophores were
utilized to tag DNA strands during simulation of drug release and
track attachment to the AuNP platform. Single-stranded DNA
tethers were successfully conjugated to AuNPs by gold-thiol bond
formation using a 5’ thiol DNA modifier, but synthesizing the full
AuNP platform proved to be more challenging. After attempting
several attachment sequences and methods, there were no visible
indications of successful attachment of dsDNA tethers to the AuNP
platform. Future work will consist of identifying what is preventing
the full dsDNA tethers from attaching or if its attachment is being
masked. Finally, efforts will turn to synthesizing AuNPs with both
DNA tethers attached which are able to denature independently at
different temperatures to achieve a timed and temperaturedependent dual-drug release.
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DNA Tether Sequences
Thiolseq44.2 : 5' - Thiol - ATA AGT CAT CGT ATT GTA TAG -3'
LENGTH: 21
GC CONTENT: 28.6 %
MELT TEMP: 44.2 ºC

3'TYEcompseq44.2 : 5' - CTA TAC AAT ACG ATG ACT TAT - (TYE) - 3'
5'TYEcompseq44.2 : 5' - (TYE) - CTA TAC AAT ACG ATG ACT TAT - 3'

Two complementary sequences with TYE665 attached at opposite ends were developed in
order to investigate the effect of fluorescent quenching
Thiolseq60.7 : 5' - Thiol - TAT GTG GCG TAA GTC CTA AGA GTT -3'
3'FAMcompseq60.7 : 5' - ATA CAC CGC ATT CAG GAT TCT CAA - (FAM) - 3'

LENGTH: 24
GC CONTENT: 41.7 %
MELT TEMP: 60.7 ºC

5'FAMcompseq60.7 : 5' - (FAM) - ATA CAC CGC ATT CAG GAT TCT CAA - 3'
The FAM tagged dsDNA sequence was developed with a melting temperature significantly
higher than the TYE strand (~15ᵒC higher) in order to achieve timed release. This difference
arises from its greater length and higher GC content.

FAM and TYE665 Emission/Excitation Spectra
TYE and FAM
were used to track
DNA denaturation
due to their
emission at
different
distinguishable
wavelengths; this
allows for
detection of each
fluorophore
separately within
the same sample.

Two approaches were implemented to form the DNA-AuNP platform: 1.) Complementary
thiolated and fluorescent ssDNA strands were hybridized together and then conjugated to
the AuNP by a gold-thiol bond; and 2.) The thiolated ssDNA strand was conjugated to the
AuNP first, followed by hybridization of its complementary fluorescent ssDNA strand.

Unsuccessful
hybridization of
Fluorescent DNA

The AuNP tumor targeting platform consists of two dsDNA strands of different
lengths and different melting temperatures (Tm) conjugated to a gold
nanoparticle via gold-thiol bonds. Each non-thiolated complementary strand of
DNA is tagged with either fluorescein (FAM) fluorophore or TYE665
fluorophore (a modified Cy5 substitute) for tracking temperature-sensitive
release. The platform is also stabilized by Polyethylene Glycol (PEG) not
shown in this diagram.

Centrifugation of newly synthesized DNA-AuNP
conjugates revealed significant fluorescence in
the supernatant and very little if any on the DNAAuNP conjugates, indicating that the majority of
TYE665 tagged DNA did not attach.

Surface Enhanced
Raman
Spectroscopy
(SERS) of DNA-AuNP
conjugates (left)
indicates some
fluorescent DNA
attached to the
surface of the AuNP
but there was no
fluorescence on pure
AuNP samples (right)

Conclusions and Ongoing Research

Conjugation and Hybridization of DNA-AuNPs
General Structure of AuNP Targeting Platform

Fluorescence samples of free single-stranded
TYE665 tagged DNA dilutions indicate a
detection limit of approximately 0.5 mM,
suggesting that dsDNA tethers could be on the
AuNP surface at an undetectable concentration.

AuNP platforms were successfully synthesized and conjugated with
each of the designed ssDNA strands. However, lack of fluorescence on
the AuNP platform indicated that either hybridization and conjugation of
either fluorescent dsDNA tether was unsuccessful or was being masked
by fluorescent quenching. Fluorescence and SERS data suggest the
possibility of successful DNA tether attachment at a concentration
below the fluorimeter detection limit. Further experimentation will be
focused on the following:
•
Exploration of different DNA tether attachment techniques
•
Achieving full AuNP delivery platform assembly with both DNA
tethers and stabilizing PEG
•
Quantification and Analysis of timed temperature-sensitive DNA
release
•
Loading the AuNP platform with anticancer drugs and optimizing
payload delivery in living organisms to increase selectivity and
efficacy of cancer treatment

‘laying down’ of
hybridized and
conjugated DNA on the
surface of the AuNP
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